CMP-001 for Relapsed and Refractory Lymphoma

NCT03983668 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

14

Enrollment

OTHER

Sponsor class

Stopped Manufacturing issue with investigational drug

Conditions

Lymphoma

Interventions

DRUG: CMP-001
DRUG: Pembrolizumab

Sponsor

Umar Farooq

Collaborators

[object Object]
[object Object]
[object Object]